+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dendritic Cell Cancer Vaccine"

From
From
From
From
From
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

The Dendritic Cell Cancer Vaccine is a type of cancer vaccine that uses a patient's own dendritic cells to stimulate an immune response against cancer cells. Dendritic cells are a type of white blood cell that can recognize and respond to foreign substances in the body. The vaccine works by extracting dendritic cells from the patient's blood, loading them with antigens from the patient's cancer cells, and then reintroducing them into the patient's body. This stimulates the patient's immune system to recognize and attack the cancer cells. The Dendritic Cell Cancer Vaccine market is a rapidly growing segment of the cancer vaccine market. It is a promising approach to cancer treatment, as it is personalized to the patient and has the potential to be more effective than traditional cancer treatments. Companies in the Dendritic Cell Cancer Vaccine market include Immunovative Therapies, Inc., ImmunoCellular Therapeutics, Ltd., and OncoImmune, Inc. Show Less Read more